Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76851 - 76875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamoxifen	Approved Investigational	MST1	4485	upregulated	Tamoxifen results in increased expression of MST1 mRNA	3p21.31	A21112
Tamoxifen	Approved Investigational	MTHFR	4524	downregulated	Tamoxifen results in decreased expression of MTHFR mRNA	1p36.22	A21115
Tamoxifen	Approved Investigational	MTMR2	8898	upregulated	Tamoxifen results in increased expression of MTMR2 mRNA	11q21	A21115
Tamoxifen	Approved Investigational	MX1	4599	upregulated	Tamoxifen results in increased expression of MX1 mRNA	21q22.3	A24384
Tamoxifen	Approved Investigational	MYC	4609	downregulated	Tamoxifen results in decreased expression of MYC mRNA	8q24.21	A21175
Tamoxifen	Approved Investigational	MYCBP	26292	upregulated	Tamoxifen results in increased expression of MYCBP mRNA	1p34.3	A24383
Tamoxifen	Approved Investigational	MYOD1	4654	downregulated	Tamoxifen results in decreased expression of MYOD1 mRNA	11p15.1	A21264
Tamoxifen	Approved Investigational	NCOA1	8648	upregulated	Tamoxifen results in increased expression of NCOA1 mRNA	2p23.3	A21264 A24388
Tamoxifen	Approved Investigational	NCOA2	10499	upregulated	Tamoxifen results in increased expression of NCOA2 mRNA	8q13.3	A24388
Tamoxifen	Approved Investigational	NCOA3	8202	upregulated	Tamoxifen results in increased expression of NCOA3 mRNA	20q13.12	A22730 A24388
Tamoxifen	Approved Investigational	NCOR2	9612	downregulated	Tamoxifen results in decreased expression of NCOR2 mRNA	12q24.31	A21264
Tamoxifen	Approved Investigational	NFIX	4784	downregulated	Tamoxifen results in decreased expression of NFIX mRNA	19p13.13	A21115
Tamoxifen	Approved Investigational	NFKB1	4790	upregulated	Tamoxifen results in increased expression of NFKB1 mRNA	4q24	A3616
Tamoxifen	Approved Investigational	NFKBIA	4792	downregulated	Tamoxifen results in decreased expression of NFKBIA mRNA	14q13.2	A21168
Tamoxifen	Approved Investigational	NKD1	85407	upregulated	Tamoxifen results in increased expression of NKD1 mRNA	16q12.1	A21164
Tamoxifen	Approved Investigational	NOVA1	4857	downregulated	Tamoxifen results in decreased expression of NOVA1 mRNA	14q12	A24383
Tamoxifen	Approved Investigational	NR0B2	8431	upregulated	Tamoxifen results in increased expression of NR0B2 mRNA	1p36.11	A20438 A20430
Tamoxifen	Approved Investigational	NUPR1	26471	upregulated	Tamoxifen results in increased expression of NUPR1 mRNA	16p11.2	A20430 A20646
Tamoxifen	Approved Investigational	OAS1	4938	upregulated	Tamoxifen results in increased expression of OAS1 mRNA	12q24.2	A24384
Tamoxifen	Approved Investigational	OAS3	4940	upregulated	Tamoxifen results in increased expression of OAS3 mRNA	12q24.13	A24384
Tamoxifen	Approved Investigational	OSBPL7	114881	upregulated	Tamoxifen results in increased expression of OSBPL7 mRNA	17q21	A21112
Tamoxifen	Approved Investigational	PARG	8505	upregulated	Tamoxifen results in increased expression of PARG mRNA	10q11.23	A24383
Tamoxifen	Approved Investigational	PCLAF	9768	downregulated	Tamoxifen results in decreased expression of PCLAF mRNA	15q22.31	A3616
Tamoxifen	Approved Investigational	PGC	5225	downregulated	Tamoxifen results in decreased expression of PGC mRNA	6p21.1	A24383
Tamoxifen	Approved Investigational	PGGT1B	5229	upregulated	Tamoxifen results in increased expression of PGGT1B mRNA	5q22.3	A3616

Displaying entries 76851 - 76875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability